1
|
Ferreira GN, Monteiro GA, Prazeres DM and
Cabral JM: Downstream processing of plasmid DNA for gene therapy
and DNA vaccine applications. Trends Biotechnol. 18:380–388. 2000.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Knipe JM, Peters JT and Peppas NA:
Theranostic agents for intracellular gene delivery with
spatiotemporal imaging. Nano Today. 8:21–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Nam HY, Park JH, Kim K, Kwon IC and Jeong
SY: Lipid-based emulsion system as non-viral gene carriers. Arch
Pharm Res. 32:639–646. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Wang Y, Miao L, Satterlee A and Huang L:
Delivery of oligonucleotides with lipid nanoparticles. Adv Drug
Deliv Rev. 87:68–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhao Y and Huang L: Lipid nanoparticles
for gene delivery. Adv Genet. 88:13–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Malone RW, Felgner PL and Verma IM:
Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci
USA. 86:6077–6081. 1989. View Article : Google Scholar : PubMed/NCBI
|
7
|
Schroeder A, Levins CG, Cortez C, Langer R
and Anderson DG: Lipid-based nanotherapeutics for siRNA delivery. J
Intern Med. 267:9–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Fehring V, Schaeper U, Ahrens K, Santel A,
Keil O, Eisermann M, Giese K and Kaufmann J: Delivery of
therapeutic siRNA to the lung endothelium via novel Lipoplex
formulation DACC. Mol Ther. 22:811–820. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Bergen JM, Park IK, Horner PJ and Pun SH:
Nonviral approaches for neuronal delivery of nucleic acids. Pharm
Res. 25:983–998. 2008. View Article : Google Scholar :
|
10
|
Jokerst JV, Lobovkina T, Zare RN and
Gambhir SS: Nanoparticle PEGylation for imaging and therapy.
Nanomedicine (Lond). 6:715–728. 2011. View Article : Google Scholar
|
11
|
Li SD and Huang L: Nanoparticles evading
the reticuloendothelial system: Role of the supported bilayer.
Biochim Biophys Acta. 1788:2259–2266. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Huang L and Liu Y: In vivo delivery of
RNAi with lipid-based nanoparticles. Annu Rev Biomed Eng.
13:507–530. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Majzoub RN, Chan CL, Ewert KK, Silva BF,
Liang KS, Jacovetty EL, Carragher B, Potter CS and Safinya CR:
Uptake and transfection efficiency of PEGylated cationic
liposome-DNA complexes with and without RGD-tagging. Biomaterials.
35:4996–5005. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Lee YK, Lee TS, Song IH, Jeong HY, Kang
SJ, Kim MW, Ryu SH, Jung IH, Kim JS and Park YS: Inhibition of
pulmonary cancer progression by epidermal growth factor
receptor-targeted transfection with Bcl-2 and survivin siRNAs.
Cancer Gene Ther. 22:335–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Baek SE, Lee KH, Park YS, Oh DK, Oh S, Kim
KS and Kim DE: RNA aptamer-conjugated liposome as an efficient
anticancer drug delivery vehicle targeting cancer cells in vivo. J
Control Release. 196:234–242. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yoo MK, Kang SK, Choi JH, Park IK, Na HS,
Lee HC, Kim EB, Lee NK, Nah JW, Choi YJ, et al: Targeted delivery
of chitosan nanoparticles to Peyer’s patch using M cell-homing
peptide selected by phage display technique. Biomaterials.
31:7738–7747. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Portnoy E, Lecht S, Lazarovici P, Danino D
and Magdassi S: Cetuximab-labeled liposomes containing
near-infrared probe for in vivo imaging. Nanomedicine. 7:480–488.
2011.PubMed/NCBI
|
18
|
Sato JD, Kawamoto T, Le AD, Mendelsohn J,
Polikoff J and Sato GH: Biological effects in vitro of monoclonal
antibodies to human epidermal growth factor receptors. Mol Biol
Med. 1:511–529. 1983.PubMed/NCBI
|
19
|
Kang IC, Chung KH, Lee SJ, Yun Y, Moon HM
and Kim DS: Purification and molecular cloning of a platelet
aggregation inhibitor from the snake (Agkistrodon halys
brevicaudus) venom. Thromb Res. 91:65–73. 1998. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kang IC, Lee YD and Kim DS: A novel
disintegrin salmosin inhibits tumor angiogenesis. Cancer Res.
59:3754–3760. 1999.PubMed/NCBI
|
21
|
Nishitani M, Sakai T, Kanayama H, Himeno K
and Kagawa S: Cytokine gene therapy for cancer with naked DNA. Mol
Urol. 4:47–50. 2000. View Article : Google Scholar
|
22
|
Park YS, Kim KS, Lee YK, Kim JS, Baek JY
and Huang L: Inhibition of TC-1 tumor progression by cotransfection
of Saxatilin and IL-12 genes mediated by lipofection or
electroporation. Oncol Res. 18:203–212. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Goodwin T and Huang L: Nonviral vectors:
We have come a long way. Adv Genet. 88:1–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Tam YY, Chen S and Cullis PR: Advances in
lipid nanoparticles for siRNA delivery. Pharmaceutics. 5:498–507.
2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Whitehead KA, Dorkin JR, Vegas AJ, Chang
PH, Veiseh O, Matthews J, Fenton OS, Zhang Y, Olejnik KT, Yesilyurt
V, et al: Degradable lipid nanoparticles with predictable in vivo
siRNA delivery activity. Nat Commun. 5:42772014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhao Y, Zhang S, Zhang Y, Cui S, Chen H,
Zhi D, Zhen Y, Zhang S and Huang L: Tri-peptide cationic lipids for
gene delivery. J Mater Chem B Mater Biol Med. 3:119–126. 2015.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Huang X, Schwind S, Yu B, Santhanam R,
Wang H, Hoellerbauer P, Mims A, Klisovic R, Walker AR, Chan KK, et
al: Targeted delivery of microRNA-29b by transferrin-conjugated
anionic lipopolyplex nanoparticles: A novel therapeutic strategy in
acute myeloid leukemia. Clin Cancer Res. 19:2355–2367.
2013.PubMed/NCBI
|
28
|
Li SD and Huang L: Stealth nanoparticles:
High density but sheddable PEG is a key for tumor targeting. J
Control Release. 145:178–181. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhao YN, Qureshi F, Zhang SB, Cui SH, Wang
B, Chen HY, Lv HT, Zhang SF and Huang L: Novel gemini cationic
lipids with carbamate groups for gene delivery. J Mater Chem B
Mater Biol Med. 2:2920–2928. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Askarian S, Abnous K, Taghavi S, Oskuee RK
and Ramezani M: Cellular delivery of shRNA using aptamer-conjugated
PLL-alkyl-PEI nanoparticles. Colloids Surf B Biointerfaces.
136:355–364. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Shi C, Gao F, Gao X and Liu Y: A novel
anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier
system: Physical characterization and cellular uptake evaluation in
vitro and in vivo. Biomed Pharmacother. 69:191–200. 2015.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Xie X, Yang Y, Yang Y and Mei X:
Photolabile-caged peptide-conjugated liposomes for siRNA delivery.
J Drug Target. 23:789–799. 2015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Eliaz RE and Szoka FC Jr:
Liposome-encapsulated doxorubicin targeted to CD44: A strategy to
kill CD44-overexpressing tumor cells. Cancer Res. 61:2592–2601.
2001.PubMed/NCBI
|
34
|
Kim HS, Song IH, Kim JC, Kim EJ, Jang DO
and Park YS: In vitro and in vivo gene-transferring characteristics
of novel cationic lipids, DMKD (O,O’-dimyristyl-N-lysyl aspartate)
and DMKE (O,O’-dimyristyl-N-lysyl glutamate). J Control Release.
115:234–241. 2006. View Article : Google Scholar : PubMed/NCBI
|
35
|
Dokka S, Toledo D, Shi X, Castranova V and
Rojanasakul Y: Oxygen radical-mediated pulmonary toxicity induced
by some cationic liposomes. Pharm Res. 17:521–525. 2000. View Article : Google Scholar : PubMed/NCBI
|
36
|
Hafez IM, Maurer N and Cullis PR: On the
mechanism whereby cationic lipids promote intracellular delivery of
polynucleic acids. Gene Ther. 8:1188–1196. 2001. View Article : Google Scholar : PubMed/NCBI
|
37
|
Kim SI, Kim KS, Kim HS, Kim DS, Jang Y,
Chung KH and Park YS: Inhibitory effect of the salmosin gene
transferred by cationic liposomes on the progression of B16BL6
tumors. Cancer Res. 63:6458–6462. 2003.PubMed/NCBI
|
38
|
Kim HS, Jeong HY, Lee YK, Kim KS and Park
YS: Synergistic antitumoral effect of IL-12 gene cotransfected with
antiangiogenic genes for angiostatin, endostatin, and saxatilin.
Oncol Res. 21:209–216. 2013. View Article : Google Scholar
|